for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Valeant announces pricing for Siliq

April 21 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant’s patient access and pricing committee announces pricing for Siliq(brodalumab) as the lowest priced injectable biologic for moderate-to-severe plaque psoriasis

* Valeant - sales and marketing of Siliq are expected to commence in U.S. During second half of 2017

* Valeant - decided to list Siliq injection, at $3,500 per month

* Valeant - Siliq will also be included in company’s patient access program to further offer financial support and access to patients Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up